You are here
Clinical Trials: Heart Disease
Each Clinical Trial will open in a new browser window or tab.
Conditions: Heart Disease, Ischemic; Hyperlipidemias; Hypertension
Intervention: Other: Whole-Food, Plant-Based Diet and Low-Carbohydrate Diet
Sponsor: University of Rochester
Not yet recruiting
Intervention: Other: Whole-Food, Plant-Based Diet and Low-Carbohydrate Diet
Sponsor: University of Rochester
Not yet recruiting
Conditions: Congestive Heart Failure; Angina
Intervention: Biological: AlloRx
Sponsor: The Foundation for Orthopaedics and Regenerative Medicine
Recruiting
Intervention: Biological: AlloRx
Sponsor: The Foundation for Orthopaedics and Regenerative Medicine
Recruiting
Condition: Chronic Ischemic Left Ventricular Dysfunction
Interventions: Drug: Human Embryonic Stem Cell-Derived Cardiomyocyte 50M cells; Drug: Human Embryonic Stem Cell-Derived Cardiomyocyte 150 cells; Drug: Human Embryonic Stem Cell-Derived Cardiomyocyte 300M cells
Sponsor: Joseph C. Wu
Not yet recruiting
Interventions: Drug: Human Embryonic Stem Cell-Derived Cardiomyocyte 50M cells; Drug: Human Embryonic Stem Cell-Derived Cardiomyocyte 150 cells; Drug: Human Embryonic Stem Cell-Derived Cardiomyocyte 300M cells
Sponsor: Joseph C. Wu
Not yet recruiting
Conditions: Myocardial Infarction, Acute; Myocardial Infarction First; Myocardial Infarction, Anterior Wall; Cardiac Remodeling, Ventricular; STEMI; Regenerative Medicine; Heart Failure
Interventions: Biological: Umbilical Cord-Derived Wharton's Jelly Mesenchymal Stem Cells (WJ-MSCs); Other: Conventional Treatment
Sponsors: Shiraz University of Medical Sciences; National Institute of Medical Research Development (NIMAD), Iran; Cell Tech Pharmed Company, Iran
Recruiting
Interventions: Biological: Umbilical Cord-Derived Wharton's Jelly Mesenchymal Stem Cells (WJ-MSCs); Other: Conventional Treatment
Sponsors: Shiraz University of Medical Sciences; National Institute of Medical Research Development (NIMAD), Iran; Cell Tech Pharmed Company, Iran
Recruiting
Conditions: Ischemic Heart Disease; Lung Injury; Non-cardiac Surgery
Interventions: Biological: human umbilical cord-derived mesenchymal stem cells; Other: saline
Sponsor: Shanghai East Hospital
Recruiting
Interventions: Biological: human umbilical cord-derived mesenchymal stem cells; Other: saline
Sponsor: Shanghai East Hospital
Recruiting
Condition: Heart Failure, Systolic
Interventions: Biological: human umbilical cord mesenchymal stem cells; Other: human serum albumin
Sponsor: Shanghai East Hospital
Not yet recruiting
Interventions: Biological: human umbilical cord mesenchymal stem cells; Other: human serum albumin
Sponsor: Shanghai East Hospital
Not yet recruiting
Conditions: Myocardial Ischemia; Ventricular Dysfunction, Left
Intervention: Biological: Allogeneic Human Umbilical Cord Mesenchymal Stem Cells
Sponsor: Shanghai East Hospital
Recruiting
Intervention: Biological: Allogeneic Human Umbilical Cord Mesenchymal Stem Cells
Sponsor: Shanghai East Hospital
Recruiting
Condition: Hypoplastic Left Heart Syndrome
Intervention: Biological: Lomecel-B medicinal signaling cells
Sponsors: Ann & Robert H Lurie Children's Hospital of Chicago; National Heart, Lung, and Blood Institute (NHLBI); The University of Texas Health Science Center, Houston; Longeveron Inc.
Recruiting
Intervention: Biological: Lomecel-B medicinal signaling cells
Sponsors: Ann & Robert H Lurie Children's Hospital of Chicago; National Heart, Lung, and Blood Institute (NHLBI); The University of Texas Health Science Center, Houston; Longeveron Inc.
Recruiting
Condition: Heart Transplantation
Intervention: Biological: Autologous thyTreg
Sponsors: Rafael Correa-Rocha; Instituto de Salud Carlos III; Fundación Familia Alonso
Recruiting
Intervention: Biological: Autologous thyTreg
Sponsors: Rafael Correa-Rocha; Instituto de Salud Carlos III; Fundación Familia Alonso
Recruiting
Condition: Congenital Heart Disease, SRV Dependent
Intervention: Biological: Autologous mononuclear cells
Sponsors: Timothy J Nelson, MD, PhD; Mayo Clinic; University of Oklahoma; Children's Hospital of Philadelphia; Children's Hospital Los Angeles; Children's Hospitals and Clinics of Minnesota; Children's Hospital Colorado; Ochsner Health System; Children's of Alabama; Children's Hospital Medical Center, Cincinnati; The Hospital for Sick Children
Not yet recruiting
Intervention: Biological: Autologous mononuclear cells
Sponsors: Timothy J Nelson, MD, PhD; Mayo Clinic; University of Oklahoma; Children's Hospital of Philadelphia; Children's Hospital Los Angeles; Children's Hospitals and Clinics of Minnesota; Children's Hospital Colorado; Ochsner Health System; Children's of Alabama; Children's Hospital Medical Center, Cincinnati; The Hospital for Sick Children
Not yet recruiting
2022 AlphaMed Press ©